首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration
【24h】

Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration

机译:固定化人血清白蛋白-HPLC测定药物-蛋白质结合并与超滤比较

获取原文
获取原文并翻译 | 示例
       

摘要

An HPLC method employing CHIRAL-I (150 mm x 3 mm), 5 mu m column from Chrom. Tech., immobilized with human serum albumin (HSA), was used to determine in vitro protein binding of several compounds. Experimentally obtained plasma protein data exhibited good correlation with the reported values. The method was compared with the conventional ultra filtration technique and both yielded similar results. Proprietary compounds that could not be analyzed by ultra filtration due to high non-specific binding to filter membrane were successfully analyzed by HSA-HPLC method. On the other hand, two proprietary compounds did not elute from HSA column due to strong binding, but were successfully analyzed by ultra filtration. This proves that both the techniques have their own merits and demerits and should be exploited judiciously as per the requirement. The plasma protein binding studies conducted on four gyrase inhibitors in rat and human plasma exhibited no interspecies difference via ultra filtration method. Further, it was also observed that the protein binding obtained for the four gyrase inhibitors by HSA-HPLC method was not only similar to that obtained by ultra filtration in human plasma but was also in accordance with ex vivo and in vitro protein binding obtained for rat plasma after ultra filtration because these compounds predominantly bind to HSA The binding of several compounds to a I-acid glycoprotein (AGP), another important plasma protein, was also examined using AGP immobilized column. However, the data could not be relied upon since some anti-bacterials and non-steroidal anti-inflammatory drugs (NSAIDS). which are known to predominantly bind to HSA, were also found to bind to AGP. (c) 2006 Elsevier B.V. All rights reserved.
机译:HPLC方法使用Chrom的CHIRAL-1(150 mm x 3 mm),5μm色谱柱。固定有人血清白蛋白(HSA)的Tech。被用于确定几种化合物的体外蛋白结合。实验获得的血浆蛋白数据与报告值显示出良好的相关性。将该方法与常规超滤技术进行了比较,两者均得出了相似的结果。通过HSA-HPLC方法成功分析了由于与滤膜的高度非特异性结合而无法通过超滤分析的专有化合物。另一方面,由于有很强的结合力,两种专有化合物并未从HSA色谱柱上洗脱下来,但已通过超滤成功地进行了分析。这证明这两种技术各有优缺点,应根据要求明智地加以利用。通过超滤法对大鼠和人血浆中的四种促旋酶抑制剂进行的血浆蛋白结合研究未显示种间差异。此外,还观察到通过HSA-HPLC方法获得的四种促旋酶抑制剂的蛋白质结合不仅与在人血浆中超滤获得的蛋白质结合相似,而且与大鼠获得的离体和体外蛋白质结合一致。超滤后的血浆,因为这些化合物主要与HSA结合。还使用AGP固定柱检查了几种化合物与另一种重要的血浆蛋白I酸糖蛋白(AGP)的结合。但是,由于某些抗菌药和非甾体类抗炎药(NSAIDS),因此无法依赖该数据。已知主要结合HSA的蛋白也被发现结合AGP。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号